Search
Close this search box.
Featured Article

The Negative Impact of Failing to Implement Risk-Based Quality Management

As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good news is that adoption is on the increase with companies implementing RBQM in 57% of clinical trials.
However, there is still a way to go before RBQM becomes business as usual, and adoption rates are lower among smaller companies.
So, what are the potential negative impacts of failing to implement RBQM?
Steve Young, Chief Scientific Officer at CluePoints, discusses the risks companies who fail to adopt RBQM may be leaving themselves susceptible to.

International Clinical Trials, August 2024, pages 75-77. © Samedan Ltd

Blog
10 Steps for Practical RBQM Implementation for Your Business
Blog
The Bold Future of RBQM for CROs
Blog
Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence